advanced search
Prof Marc Brown
Chair of Scientific Committee
MedPharm

Is this your profile?

About

Marc Brown, PhD, CChem, FRSC, is Chair of the Scientific Committee at MedPharm, which he co-founded in 1999.  He has been the guiding force behind all of the company’s scientific developments and intellectual property.

He has been Professor of Pharmaceutics in the School of Pharmacy, University of Hertfordshire, UK, since 2006 and has visiting/honorary professorships at the Universities of Reading, UK, and King’s College London (KCL), UK. He has more than 200 publications and 26 patents describing his work. His research interests lie mainly in drug delivery to the skin, nail and airways. To date, he has been involved in the pharmaceutical development of over 55 products that are now on the market in Europe, the Americas and Japan. Prior to MedPharm he was an academic in the Pharmacy Department at KCL.

Contributions

INDUSTRIALISATION
THE FOURTH INDUSTRIAL REVOLUTION – ROBOTICS AND THE LABORATORY
Marc Brown and Jon Lenn look at MedPharm’s implementation of automated robotic systems in enhancing workflow and the company’s plans for the future implementation of robotics in formulation development.

More contributions

NASAL
ASSESSING THE NASAL DRUG DELIVERY LANDSCAPE
Jon Volmer, Jon Lenn and Professor Marc Brown discuss the role of reconstituted nasal epithelium in intranasal drug delivery.
INDUSTRIALISATION
INNOVATION AND AUTOMATION IN TOPICAL FORMULATION DEVELOPMENT
Marc Brown, Jon Lenn and Charles Evans discuss the challenges faced by the pharmaceutical industry during the development of topical delivery formulations, and how MedPharm’s performance testing models help identify and mitigate risks during the process.
OCULAR
THE CHALLENGES AND OPPORTUNITIES OF DRUG DELIVERY THROUGH A COMPLEX BARRIER
Jon Volmer, Marc Brown and Jeremy Drummond discuss the development and use of advanced ex vivo and in vitro models for testing new ocular medicines to meet a growing unmet need.
SKIN
COST-EFFECTIVE APPROACHES FOR SUCCESSFUL GENERIC DERMAL DRUG PRODUCT AUTHORISATIONS
Marc Brown, Jon Lenn and Jeremy Dummond discuss various methods and advantages of in vitro bioequivalence studies for topical skin application, and how MedPharm’s unique technologies and experience can be invaluable in the effective development of generics in this field.
#65 Mar 2016 MedPharm featured
TRANSDERMAL
NEW RESEARCH TOOLS FOR TOPICAL & TRANSDERMAL DEVELOPMENT
Marc Brown, Rob Turner and James Gibbons provide a view on the current topical and transdermal market, elaborate on some of the common approaches to product development in this area, and reveal the company’s newest model, the MedFlux-HT™ system.
TRANSDERMAL
AQUARMED™: TRANSDERMAL DELIVERY USING NOVEL COMPONENTS
Marc Brown, Adrian Williams and James Gibbons explain how the company has developed AquaRMed and describe the potential benefits it could offer patients and companies alike.
PULMONARY
ARTIFICIAL NEURAL NETWORKS & TISSUE MODELS
Marc Brown, Jo Muddle and Professor Clive Page describe the use of artificial neural networks and novel tissue models as methods for formulation candidate screening, selection and characterisation and, in generic product development, for bioequivalence testing.
Top